Prophylactic

ApprovedSmall molecule

Amgen

Prophylactic is one of 44 small molecule programs targeting Ventral Hernia. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ventral HerniaActive, not recruiting

MigraineActive, not recruiting

Ventral HerniaPreclinical

Active, not recruiting

MigraineApproved

Active, not recruiting

Competition

Competitive Landscape

357 competitors in Migraine

#DrugCompanyPhaseTrials

Prophylactic

Amgen

Approved

2 2

Bayer Aspirin

Bayer

Preclinical

2 3

Savella

AbbVie

Preclinical

2 4

Botox

RRevance Therapeutics, Inc.

Preclinical

9 5

Cervidil

Pfizer

Preclinical

1 6

Adempas

Bayer

Preclinical

1 7

Viagra

VViatris Specialty LLC

Preclinical

2 8

Nitrostat

VViatris Specialty LLC

Preclinical

2 9

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

1 10

Pristiq

PPrism Pharmaceuticals

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Migraine2 trials

Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients

Completed· Amgen logo

Amgen·Phase 4·NCT03927144·621 enrolled

Mindfulness Therapy for Chronic Migraine

Completed·FFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta·Phase 4·NCT03671681·177 enrolled

Ventral Hernia1 trial

Use of Mosquito Net Mesh for Ventral Hernia Repair

Unknown status·HHospital Central "Dr. Ignacio Morones Prieto"·N/A·NCT03324854·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Prophylactic. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Prophylactic compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Prophylactic. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Amgen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Amgen

Prophylactic

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Migraine2 trials

Ventral Hernia1 trial

References

Drug Info

Quick Facts

Related News